Organ transplantation from donors with hepatitis C virus antibodies in their blood
Maleev Vv, Ruslan Alikhanov(Moscow Clinical Scientific Center), M. Sh. Khubutia(Moscow State University of Medicine and Dentistry), В. Л. Коробка, S.E. Voskanyan, С. Ф. Багненко(First Pavlov State Medical University of St. Petersburg), Е. Н. Бессонова(Ural State Medical University), Vladimir Chulanov(Université Claude Bernard Lyon 1), М. Г. Минина(The Coordinating Center), Ya. G. Moysyuk(Regional Clinical Research), Д. А. Гранов, K.K. Gubarev, E. V Volchkova, V. Е. Syutkin(Université Claude Bernard Lyon 1), М. С. Новрузбеков
Cited by 0
Related Papers
The critical pathway for deceased donation: reportable uniformity in the approach to deceased donation
|Transplant International|2011|234
The present and future disease burden of hepatitis <scp>C</scp> virus (<scp>HCV</scp>) infections with today's treatment paradigm – volume 2
|Journal of Viral Hepatitis|2015|125
Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in select countries – volume 2
|Journal of Viral Hepatitis|2015|93
Randomized Trial of Micafungin for the Prevention of Invasive Fungal Infection in High-Risk Liver Transplant Recipients
|Clinical Infectious Diseases|2014|81
Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D
|New England Journal of Medicine|2024|77